HOME | PUBLISHER | ISSUE 4 (OCTOBER - DECEMBER) 2016 | ACCESS INDEXES FOR ALL VOLUMES

Valid CSS! Valid HTML 4.01 Transitional

PDF|Print Shopping cart for future issues to go here

Free to read online.

HUMANITIES SCIENCE POLITICS

Science, People & Politics ISSN 1751-598x, 25th November, 2016. 18.00 GMT

ALDERELEY PARK FEATURE | 11

and lab and communal spaces within 400-acres. The business model is
that BioHub start ups migrate out to become mainstream S.M.Es (small
and medium sized enterprises) in the Science Park.

I asked about current and planned cyber and IT security. Bowden's
answer was unclear, but he was probably the wrong person to ask. As
things stand now, with Astra Zeneca corporate and in vivo facilities on
site, I am assuming security at all levels is tight. Anything other would
be corporate negligence of breathtaking proportions, and Astra Zeneca's
numbers, science and corporate reception desk at Alderley Park give no
indication of the them being other than ruthless, competent capitalists.

As a physical entity Alderley Park is a compact assemblage of scientific
real estate in a pretty setting. OK, I admit it, my language is influenced
by having downloaded from Companies House the latest consolidated
accounts of the site's ultimate major corporate parent, Bruntwood Ltd.

To my eye, untutored in this field, the corporate structure looks compli-
cated. Additionally I do not have the accounting competence to say how
deeply rooted is the attractiveness of its consolidated solvency.

>Companies House received the most recent consolidated accounts for
Bruntwood Ltd. on 1st February, 2016, made up to 30th September 2015.
Given its history, the demands of company law and HMRC, Bruntwood
must currently be at a critical stage of preparing to report its next
consolidated annual accounts.

SO MUCH FOR THE SUPERSTRUCTURE

From Bowden my handlers delivered me through locked doors to the
Medicines' Discovery Catapult, a UK government initiative. Not, however,
before Bowden and I stopped to admire the giant molecular model of an
Astra Zeneca drug outside the coffee shop. I took its picture, intrigued
by the business-like nature of the two sentinel chlorines reaching up-
ward. Ready for anything, if you ask me. Not sure where my handlers
were at this stage.

My next two interviewees were the chairman and chief executive officer

Continued on page 12...

Issue 4 (October - December), 2016. Volume VII. Science, People & Politics ISSN 1751-598x.

|
|
|
|
|
|
|
|
|

CONTENTS

P3

P4

P5

P6

P7

P8

P9

P10

P11

P12

P13

P14

P15

P16

P17

P18

P19

P20

P21

Published Friday 25th November, 2016

P23

P24

P25

P26

P27

P28

P29

P30

P31

P32

P33

P34

P35

P36

P37

A print version would additionally have two blank pages, so this version is not routinely for sale as print, unless really wanted.

HTML/CSS by Helen Gavaghan©